User login

Life Sciences & Biotechnology, Healthcare and Well-Being

The BRT's current Working Party 2 (WP2) addresses "Life Sciences & Biotechnology, Healthcare and Well-Being" issues and prepares recommendations to the Government of Japan and to the EU Authorities on these topics.

For information on the role and work of the BRT's 4 Working Parties, click here.

WP2's EU-side is led by Bayer Holding Ltd. Chugai Pharmaceutical Co., Ltd. leads its Japan-side. A 'Life Sciences & Biotechnology' working party was established in time for the 2004 BRT, having held pilot discussions at the 2003 meeting. Over the years the exact title of the working parties have evolved to reflect their changing remit.

Since 2009, the BRT has released several sets of Recommendations in these areas:

Year Title of relevant Working Party Recommendation document(s)
2016 Life Sciences & Biotechnology, Healthcare & Well-Being
2015 Life Sciences and Biotechnologies, Healthcare and Well-being
2014 Life Sciences and Biotechnologies, Healthcare and Well-being
2013 Life Sciences and Biotechnologies, Healthcare and Well-being
2012 Life Sciences and Biotechnologies, Healthcare and Well-being
2011 Life Sciences and Biotechnologies, Healthcare and Well-being
2010 Life Sciences and Biotechnologies
2009 Life sciences and Biotechnology